Brief: Quantum Genomics completes patient enrolment for phase IIa QGC001 trial
05/01/2016 17:05
Jan 5 (Reuters) - Quantum Genomics SA ALQGC.PA :
* Announces the recruitment of 100 pct of patients in the
clinical study phase IIa in hypertension for candidate drug
QGC001
Source text: http://bit.ly/1RpoZYA
Further company coverage: ALQGC.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Quantum Genomics SA
See all newsBrief: Quantum Genomics Announces Resumption Of Discussions With HealthTech, Terminates Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO
Brief: Quantum Genomics In Talks For New Strategic Project
Brief: Quantum Genomics Announces Lack Of Significant Efficacy For Firibastat In Their Phase Iii Study